Background: Platelet storage is complicated by deleterious changes that cause progressive structural and functional damages, so-called platelet storage lesion (PSL). PSL is commonly manifested by augmented platelet activation which is also associated with the increased levels of reactive oxygen species (ROS). Whether ROS generation increases during the storage of platelet concentrates and whether it will be correlated with P-selectin expression as a valid marker of platelet activation was investigated in this study. Methods: In our experimental study, six PRP-platelet concentrates were randomly obtained from Iranian Blood Transfusion Organization (IBTO). All the platelet products met the standard quality assessment based on AABB guideli...
Background: Pathogen inactivation methods for platelet concentrates are increasingly being used in b...
Background: Stored platelet concentrates (PC) are in increasing demand for transfusion to patients w...
Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet concentra...
Background : Recent studies suggested that platelets can be activated during the preparation of plat...
Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet concentra...
Background and ObjectivesStorage lesions may prevent transfused platelets to respond to agonists and...
Background and ObjectivesStorage lesions may prevent transfused platelets to respond to agonists and...
To access publisher's full text version of this article click on the hyperlink belowModern health ca...
To access publisher's full text version of this article click on the hyperlink belowModern health ca...
Platelet storage and its availability for transfusion are limited to 5-6 days. Oxidative stress (OS)...
BACKGROUND: The different production methods for platelet concentrates (PCs) result in products with...
BACKGROUND: The different production methods for platelet concentrates (PCs) result in products with...
Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet concentra...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
Platelets are transfused to patients to prevent bleeding. Since both preparation and storage can imp...
Background: Pathogen inactivation methods for platelet concentrates are increasingly being used in b...
Background: Stored platelet concentrates (PC) are in increasing demand for transfusion to patients w...
Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet concentra...
Background : Recent studies suggested that platelets can be activated during the preparation of plat...
Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet concentra...
Background and ObjectivesStorage lesions may prevent transfused platelets to respond to agonists and...
Background and ObjectivesStorage lesions may prevent transfused platelets to respond to agonists and...
To access publisher's full text version of this article click on the hyperlink belowModern health ca...
To access publisher's full text version of this article click on the hyperlink belowModern health ca...
Platelet storage and its availability for transfusion are limited to 5-6 days. Oxidative stress (OS)...
BACKGROUND: The different production methods for platelet concentrates (PCs) result in products with...
BACKGROUND: The different production methods for platelet concentrates (PCs) result in products with...
Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet concentra...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
Platelets are transfused to patients to prevent bleeding. Since both preparation and storage can imp...
Background: Pathogen inactivation methods for platelet concentrates are increasingly being used in b...
Background: Stored platelet concentrates (PC) are in increasing demand for transfusion to patients w...
Blood banks use pathogen inactivation (PI) technologies to increase the safety of platelet concentra...